LGALS7 and lymphoma: Conducting a comparative transcriptomic analysis between a low-tumorigenic lymphoma cell line (164T2) and its aggressive variants (S11 and S19) generated by serial in vivo passaging, our group further showed that the most prominent change that occurred in highly metastatic variants was the strong upregulation (160-fold) of galectin-7 [12].